deltatrials
Completed PHASE3 NCT00855257

Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome

Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Patients Presenting a Recent Acute Coronary Syndrome.

Sponsor: French Cardiology Society

Conditions Acute Coronary Syndrome (ACS)
Interventions Acid Nicotinique Placebo
Updated 5 times since 2017 Last updated: Jul 8, 2009 Started: Jun 30, 2007 Primary completion: May 31, 2009 Completion: May 31, 2009

Listed as NCT00855257, this PHASE3 trial focuses on Acute Coronary Syndrome (ACS) and remains completed. Sponsored by French Cardiology Society, it has been updated 5 times since 2007, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • French Cardiology Society
  • Merck Serono International SA
Data source: French Cardiology Society

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Toulouse, France